No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 16.670
- +0.380+2.33%
Trading May 20 10:42 ET
18.88BMarket Cap-39690P/E (TTM)
16.770High16.445Low1.80MVolume16.445Open16.290Pre Close30.07MTurnover0.16%Turnover RatioLossP/E (Static)1.13BShares17.13052wk High2.59P/B18.77BFloat Cap7.08552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM2.00%Amplitude3.107Historical Low16.695Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B
Express News | NYSE Order Imbalance 76140.0 Shares on Sell Side
Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing
Amir Weiss, Chief Accounting Officer, around May 15, 2024, sold 28,135 shares in Teva Pharmaceutical Industries (TEVA) for $470,794. Following the Form 4 filing with the SEC, Weiss has control over a
Teva Pharmaceutical Industries(TEVA.US) Officer Sells US$470.79K in Common Stock
$Teva Pharmaceutical Industries(TEVA.US)$ Officer Weiss Amir sold 28,135 shares of common stock on May 15, 16, 2024 at an average price of $16.7334 for a total value of $470.79K.Source: Announcement W
Express News | NYSE Order Imbalance 56007.0 Shares on Sell Side
Comments
$Teva Pharmaceutical Industries(TEVA.US$ better than anticipated revenue growth 📈
MAYDAY!!!
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
loading...
19
3
its not bad if you hold it. it's just not my thing. too many swaps and derivatives for my liking.
$Teva Pharmaceutical Industries(TEVA.US$ & alvotechpr
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
3
1
$Teva Pharmaceutical Industries(TEVA.US$ Pray Kwan Yin bless teva
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg